HK1080473A1 - Bicyclic inhibitors for hormone sensitive lipase - Google Patents

Bicyclic inhibitors for hormone sensitive lipase

Info

Publication number
HK1080473A1
HK1080473A1 HK06100358A HK06100358A HK1080473A1 HK 1080473 A1 HK1080473 A1 HK 1080473A1 HK 06100358 A HK06100358 A HK 06100358A HK 06100358 A HK06100358 A HK 06100358A HK 1080473 A1 HK1080473 A1 HK 1080473A1
Authority
HK
Hong Kong
Prior art keywords
sensitive lipase
hormone sensitive
bicyclic inhibitors
bicyclic
inhibitors
Prior art date
Application number
HK06100358A
Inventor
Petry Stefan
Beringhaus Karl-Heinz
Tennagels Norbert
Mueller Guenter
Heuer Hubert
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1080473A1 publication Critical patent/HK1080473A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
HK06100358A 2002-10-12 2006-01-10 Bicyclic inhibitors for hormone sensitive lipase HK1080473A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10247680A DE10247680B4 (en) 2002-10-12 2002-10-12 New bicyclic inhibitors of the hormone sensitive lipase
PCT/EP2003/010765 WO2004035550A1 (en) 2002-10-12 2003-09-27 Novel bicyclic inhibitors of hormone sensitive lipase

Publications (1)

Publication Number Publication Date
HK1080473A1 true HK1080473A1 (en) 2006-04-28

Family

ID=32038583

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100358A HK1080473A1 (en) 2002-10-12 2006-01-10 Bicyclic inhibitors for hormone sensitive lipase

Country Status (39)

Country Link
EP (1) EP1554259B1 (en)
JP (2) JP4658607B2 (en)
KR (1) KR20050059254A (en)
CN (1) CN100366616C (en)
AR (1) AR041565A1 (en)
AT (1) ATE349433T1 (en)
AU (1) AU2003275997B8 (en)
BR (1) BR0315257A (en)
CA (1) CA2501734C (en)
CR (1) CR7717A (en)
CY (1) CY1106358T1 (en)
DE (2) DE10247680B4 (en)
DK (1) DK1554259T3 (en)
EC (1) ECSP055729A (en)
ES (1) ES2277152T3 (en)
GT (1) GT200300214A (en)
HK (1) HK1080473A1 (en)
HN (1) HN2003000316A (en)
HR (1) HRP20050325A2 (en)
IL (1) IL167907A (en)
JO (1) JO2497B1 (en)
MA (1) MA27404A1 (en)
MX (1) MXPA05003359A (en)
MY (1) MY138057A (en)
NO (1) NO20052291L (en)
OA (1) OA12941A (en)
PA (1) PA8585101A1 (en)
PE (1) PE20040776A1 (en)
PL (1) PL374605A1 (en)
PT (1) PT1554259E (en)
RS (1) RS51543B (en)
RU (1) RU2325385C2 (en)
SV (1) SV2004001633A (en)
TN (1) TNSN05105A1 (en)
TW (1) TWI313265B (en)
UA (1) UA79994C2 (en)
UY (1) UY28015A1 (en)
WO (1) WO2004035550A1 (en)
ZA (1) ZA200501757B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005002130A1 (en) 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh New substituted aminomethylene sulfonamides useful as hormone sensitive lipase inhibitors in medicaments for treatment and/or prevention of non-insulin dependent diabetes mellitus, diabetic syndrome or obesity
DE102005026762A1 (en) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
DE102005026809A1 (en) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzothiazol-2-one derivatives as inhibitors of lipases and phospholipases
DE102005026808A1 (en) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
DE102005048897A1 (en) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazole derivatives as inhibitors of lipases and phospholipases
DE102005049953A1 (en) 2005-10-19 2007-04-26 Sanofi-Aventis Deutschland Gmbh Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
DE102005049954A1 (en) * 2005-10-19 2007-05-31 Sanofi-Aventis Deutschland Gmbh Triazolopyridine derivatives as inhibitors of lipases and phospholipases
FR2915197B1 (en) 2007-04-18 2009-06-12 Sanofi Aventis Sa TRIAZOLOPYRIDINE CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF.
FR2915198B1 (en) * 2007-04-18 2009-12-18 Sanofi Aventis TRIAZOLOPYRIDINE CARBOXAMIDE AND TRIAZOLOPYRIDINE -CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
FR2915199B1 (en) * 2007-04-18 2010-01-22 Sanofi Aventis TRIAZOLOPYRIDINE-CARBOXAMIDE AND TRIAZOLOPYRIMIDINE-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
AR072707A1 (en) 2008-07-09 2010-09-15 Sanofi Aventis HETEROCICLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION, DRUGS THAT UNDERSTAND THESE COMPOUNDS AND THE USE OF THEM
JP5657566B2 (en) * 2008-12-24 2015-01-21 バイアル ポルテラ アンド シーエイ エス エイＢＩＡＬ−Ｐｏｒｔｅｌａ ＆ Ｃａ， Ｓ．Ａ． Medicine
US8329904B2 (en) * 2009-05-12 2012-12-11 Hoffmann-La Roche Inc. Azacyclic derivatives
US8440710B2 (en) * 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US8097634B2 (en) 2010-04-15 2012-01-17 Hoffmann-La Roche Inc. Azacyclic derivatives
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8722721B2 (en) * 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US8703807B2 (en) * 2011-03-17 2014-04-22 Hoffmann-La Roche Inc. Azaspirodecanone compounds
US8809384B2 (en) * 2011-03-25 2014-08-19 Hoffmann-La Roche Inc. Azaspirodecanone compounds
UA119247C2 (en) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Spirocyclic compounds as tryptophan hydroxylase inhibitors
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015089137A1 (en) 2013-12-11 2015-06-18 Karos Pharmaceuticals, Inc. Acylguanidines as tryptophan hydroxylase inhibitors
WO2016109501A1 (en) 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Amide compounds as tryptophan hydroxylase inhibitors
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
JP2021535192A (en) 2018-11-14 2021-12-16 アルタバント・サイエンシズ・ゲーエムベーハーALTAVANT SCIENCES GmbH A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (TPH1) for treating diseases or disorders associated with peripheral serotonin.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1124716A (en) * 1978-10-20 1982-06-01 Michael J. Simons Blocked benzotriazole compounds as development restrainer precursors
DE19942354A1 (en) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, their manufacture and use in medicinal products
KR20030096348A (en) * 2001-05-05 2003-12-24 스미스클라인비이참피이엘시이 N-aroyl cyclic amines
EP1458374A2 (en) * 2001-12-14 2004-09-22 Novo Nordisk A/S Compounds and uses thereof for decreasing activity of hormone-sensitive lipase

Also Published As

Publication number Publication date
PE20040776A1 (en) 2004-12-24
MY138057A (en) 2009-04-30
RS51543B (en) 2011-06-30
EP1554259B1 (en) 2006-12-27
ES2277152T3 (en) 2007-07-01
DE50306134D1 (en) 2007-02-08
DE10247680A1 (en) 2004-04-22
AU2003275997A1 (en) 2004-05-04
CN1688555A (en) 2005-10-26
GT200300214A (en) 2007-02-05
DE10247680B4 (en) 2005-09-01
CR7717A (en) 2007-09-14
CA2501734A1 (en) 2004-04-29
SV2004001633A (en) 2004-03-19
ECSP055729A (en) 2005-07-06
EP1554259A1 (en) 2005-07-20
PL374605A1 (en) 2005-10-31
AR041565A1 (en) 2005-05-18
BR0315257A (en) 2005-08-23
MA27404A1 (en) 2005-06-01
TW200413335A (en) 2004-08-01
WO2004035550A1 (en) 2004-04-29
JP4658607B2 (en) 2011-03-23
UY28015A1 (en) 2004-04-30
KR20050059254A (en) 2005-06-17
IL167907A (en) 2010-12-30
TWI313265B (en) 2009-08-11
ATE349433T1 (en) 2007-01-15
NO20052291D0 (en) 2005-05-10
JP2006509734A (en) 2006-03-23
HN2003000316A (en) 2006-06-12
RS20050207A (en) 2007-08-03
NO20052291L (en) 2005-05-10
JO2497B1 (en) 2009-10-05
UA79994C2 (en) 2007-08-10
HRP20050325A2 (en) 2005-06-30
CN100366616C (en) 2008-02-06
JP2011026342A (en) 2011-02-10
OA12941A (en) 2006-10-13
PT1554259E (en) 2007-02-28
TNSN05105A1 (en) 2007-05-14
AU2003275997B8 (en) 2010-09-30
RU2325385C2 (en) 2008-05-27
MXPA05003359A (en) 2005-06-22
RU2005114394A (en) 2006-01-20
AU2003275997B2 (en) 2010-03-25
CA2501734C (en) 2011-05-31
ZA200501757B (en) 2005-09-07
PA8585101A1 (en) 2004-09-16
CY1106358T1 (en) 2011-10-12
DK1554259T3 (en) 2007-05-07

Similar Documents

Publication Publication Date Title
HK1080473A1 (en) Bicyclic inhibitors for hormone sensitive lipase
EG25482A (en) Inhibitors
HK1077762A1 (en) INHIBITORS OF TFGβ
HK1083443A1 (en) Thiazolidin-4-ones for inhibiting hyak3 proteins
EP1499336A4 (en) Protease inhibitors
EP1474093A4 (en) Granzyme b inhibitors
GB2412372B (en) Pyrazine-based tubulin inhibitors
EP1532133A4 (en) Nf-:b inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
EP1496354A4 (en) Substrate determining method
ZA200409686B (en) Bicyclic 6-aklylidene-penems as ?-lactamases inhibitors
AU2003249540A8 (en) Fused bicyclic metalloproteinase inhibitors
AU2003295427A8 (en) Flaviviris fusion inhibitors
AU2003269984A8 (en) Protease inhibitors
AU2003304374A8 (en) Peptide inhibitors of beta-lactamases
AU2003263738A8 (en) Protease inhibitors
EP1545520A4 (en) Multifunctional cox-2 inhibitors
SI1554259T1 (en) Novel bicyclic inhibitors of hormone sensitive lipase
AU2003267790A8 (en) Lipase inhibitors and uses thereof
GB2390185B (en) Device for predicting the presence of creatures
EP1552847A4 (en) Inhibitors for continuous activation of calcineurin
AU2003304496A8 (en) Protease inhibitors
AU2003233642A8 (en) Protease inhibitors
AU2313P (en) Passionate Pink Gaura lindheimeri
AU2003269878A8 (en) Protease inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110927